Although allocating to emerging markets has been a tall task recently, there have been pockets of companies within emerging markets that have experienced solid performance. Alejandro Saltiel lays out a capital-efficient way to allocate to emerging markets using WisdomTree’s strategies.
Read the article
We recently rebalanced our ex-State-Owned Enterprises China Index (CHXSOE). Liqian Ren highlights three major changes.
Read the article
Emerging markets are entering 2022 from a low base after their economic recovery was hindered by the resurgence of COVID-19 variants, China’s regulatory crackdown and concerns of a more hawkish Federal Reserve. Against this backdrop, Aneeka Gupta explains why investors should not ignore emerging markets this year.
Read the article
After an eventful year, many investors are asking: is investing in ex-state-owned companies in emerging markets still better than investing in the full market? Alejandro Saltiel explains why our answer is, yes.
For many emerging markets (EM) investors, navigating 2021 has felt like walking through a minefield. Joe Tenaglia explains how small caps have served as a quiet bright spot for EM investors.
The financial world seems fixated on Evergrande, the Chinese real estate company with a larger-than-life CEO and larger-than-average debt burden. Liqian Ren analyzes this latest event’s potential impact on the Chinese equity market.
